Raffles Medical Group Ltd

SGX:BSL Stock Report

Market Cap: S$1.5b

Raffles Medical Group Future Growth

Future criteria checks 3/6

Raffles Medical Group is forecast to grow earnings and revenue by 12.2% and 4% per annum respectively. EPS is expected to grow by 11.2% per annum. Return on equity is forecast to be 7.2% in 3 years.

Key information

12.2%

Earnings growth rate

11.2%

EPS growth rate

Healthcare earnings growth19.1%
Revenue growth rate4.0%
Future return on equity7.2%
Analyst coverage

Good

Last updated05 Dec 2024

Recent future growth updates

Recent updates

Raffles Medical Group (SGX:BSL) Is Reducing Its Dividend To SGD0.024

May 09
Raffles Medical Group (SGX:BSL) Is Reducing Its Dividend To SGD0.024

Raffles Medical Group's (SGX:BSL) Dividend Is Being Reduced To SGD0.024

Apr 25
Raffles Medical Group's (SGX:BSL) Dividend Is Being Reduced To SGD0.024

Raffles Medical Group's (SGX:BSL) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Apr 10
Raffles Medical Group's (SGX:BSL) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Estimating The Intrinsic Value Of Raffles Medical Group Ltd (SGX:BSL)

Nov 16
Estimating The Intrinsic Value Of Raffles Medical Group Ltd (SGX:BSL)

Raffles Medical Group (SGX:BSL) Is Doing The Right Things To Multiply Its Share Price

Nov 03
Raffles Medical Group (SGX:BSL) Is Doing The Right Things To Multiply Its Share Price

Here's Why Raffles Medical Group (SGX:BSL) Has Caught The Eye Of Investors

Aug 23
Here's Why Raffles Medical Group (SGX:BSL) Has Caught The Eye Of Investors

The Return Trends At Raffles Medical Group (SGX:BSL) Look Promising

Jul 24
The Return Trends At Raffles Medical Group (SGX:BSL) Look Promising

Raffles Medical Group (SGX:BSL) Could Easily Take On More Debt

Jun 13
Raffles Medical Group (SGX:BSL) Could Easily Take On More Debt

A Look At The Fair Value Of Raffles Medical Group Ltd (SGX:BSL)

May 30
A Look At The Fair Value Of Raffles Medical Group Ltd (SGX:BSL)

Is Now The Time To Put Raffles Medical Group (SGX:BSL) On Your Watchlist?

May 12
Is Now The Time To Put Raffles Medical Group (SGX:BSL) On Your Watchlist?

Raffles Medical Group (SGX:BSL) Is Increasing Its Dividend To SGD0.038

May 01
Raffles Medical Group (SGX:BSL) Is Increasing Its Dividend To SGD0.038

Raffles Medical Group (SGX:BSL) Might Have The Makings Of A Multi-Bagger

Mar 13
Raffles Medical Group (SGX:BSL) Might Have The Makings Of A Multi-Bagger

Estimating The Intrinsic Value Of Raffles Medical Group Ltd (SGX:BSL)

Feb 14
Estimating The Intrinsic Value Of Raffles Medical Group Ltd (SGX:BSL)

Returns At Raffles Medical Group (SGX:BSL) Are On The Way Up

Dec 04
Returns At Raffles Medical Group (SGX:BSL) Are On The Way Up

Do Raffles Medical Group's (SGX:BSL) Earnings Warrant Your Attention?

Nov 21
Do Raffles Medical Group's (SGX:BSL) Earnings Warrant Your Attention?

Is There An Opportunity With Raffles Medical Group Ltd's (SGX:BSL) 25% Undervaluation?

Oct 09
Is There An Opportunity With Raffles Medical Group Ltd's (SGX:BSL) 25% Undervaluation?

Is Raffles Medical Group (SGX:BSL) A Risky Investment?

Sep 26
Is Raffles Medical Group (SGX:BSL) A Risky Investment?

The Return Trends At Raffles Medical Group (SGX:BSL) Look Promising

Sep 01
The Return Trends At Raffles Medical Group (SGX:BSL) Look Promising

With EPS Growth And More, Raffles Medical Group (SGX:BSL) Makes An Interesting Case

Aug 20
With EPS Growth And More, Raffles Medical Group (SGX:BSL) Makes An Interesting Case

Raffles Medical Group (SGX:BSL) Has Some Way To Go To Become A Multi-Bagger

Jun 01
Raffles Medical Group (SGX:BSL) Has Some Way To Go To Become A Multi-Bagger

Raffles Medical Group (SGX:BSL) Is Increasing Its Dividend To S$0.028

May 02
Raffles Medical Group (SGX:BSL) Is Increasing Its Dividend To S$0.028

We Think Raffles Medical Group (SGX:BSL) Can Manage Its Debt With Ease

Apr 18
We Think Raffles Medical Group (SGX:BSL) Can Manage Its Debt With Ease

Slowing Rates Of Return At Raffles Medical Group (SGX:BSL) Leave Little Room For Excitement

Feb 21
Slowing Rates Of Return At Raffles Medical Group (SGX:BSL) Leave Little Room For Excitement

Raffles Medical Group (SGX:BSL) Seems To Use Debt Rather Sparingly

Oct 14
Raffles Medical Group (SGX:BSL) Seems To Use Debt Rather Sparingly

Raffles Medical Group (SGX:BSL) Has Some Way To Go To Become A Multi-Bagger

Oct 02
Raffles Medical Group (SGX:BSL) Has Some Way To Go To Become A Multi-Bagger

At S$1.40, Is Raffles Medical Group Ltd (SGX:BSL) Worth Looking At Closely?

Sep 21
At S$1.40, Is Raffles Medical Group Ltd (SGX:BSL) Worth Looking At Closely?

Here's Why I Think Raffles Medical Group (SGX:BSL) Is An Interesting Stock

Aug 12
Here's Why I Think Raffles Medical Group (SGX:BSL) Is An Interesting Stock

Here's What's Concerning About Raffles Medical Group's (SGX:BSL) Returns On Capital

Jul 01
Here's What's Concerning About Raffles Medical Group's (SGX:BSL) Returns On Capital

At S$1.08, Is It Time To Put Raffles Medical Group Ltd (SGX:BSL) On Your Watch List?

May 25
At S$1.08, Is It Time To Put Raffles Medical Group Ltd (SGX:BSL) On Your Watch List?

Earnings and Revenue Growth Forecasts

SGX:BSL - Analysts future estimates and past financials data (SGD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2026821821061225
12/31/2025785771001228
12/31/202474168-8988
6/30/2024703617297N/A
3/31/202470676120143N/A
12/31/202370890167189N/A
9/30/2023747117166189N/A
6/30/2023786144165188N/A
3/31/2023805143168192N/A
12/31/2022825143171196N/A
9/30/2022808124179204N/A
6/30/2022791104188212N/A
3/31/202275894148186N/A
12/31/202172584107160N/A
9/30/202169886108171N/A
6/30/202167188109181N/A
3/31/20216197791157N/A
12/31/20205686673133N/A
9/30/20205416042121N/A
6/30/20205085023105N/A
3/31/20205145521107N/A
12/31/20195226013111N/A
9/30/2019514631693N/A
6/30/2019504662892N/A
3/31/2019497693589N/A
12/31/2018489716294N/A
9/30/2018484716388N/A
6/30/2018483715781N/A
3/31/201848371N/A88N/A
12/31/201747871N/A83N/A
9/30/201747370N/A81N/A
6/30/201747370N/A65N/A
3/31/201747270N/A63N/A
12/31/201647470N/A79N/A
9/30/201647071N/A83N/A
6/30/201645271N/A92N/A
3/31/201643270N/A91N/A
12/31/201541169N/A73N/A
9/30/201539669N/A86N/A
6/30/201538968N/A79N/A
3/31/201538268N/A94N/A
12/31/201437568N/A93N/A
9/30/201436389N/A66N/A
6/30/201435387N/A83N/A
3/31/201434786N/A71N/A
12/31/201334185N/A71N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: BSL's forecast earnings growth (12.2% per year) is above the savings rate (2.2%).

Earnings vs Market: BSL's earnings (12.2% per year) are forecast to grow faster than the SG market (11.2% per year).

High Growth Earnings: BSL's earnings are forecast to grow, but not significantly.

Revenue vs Market: BSL's revenue (4% per year) is forecast to grow faster than the SG market (3.7% per year).

High Growth Revenue: BSL's revenue (4% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: BSL's Return on Equity is forecast to be low in 3 years time (7.2%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/21 06:09
End of Day Share Price 2024/12/20 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Raffles Medical Group Ltd is covered by 20 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
David MakCGS International
Patrick YauCitigroup Inc
Horng Han LowCLSA